Under (intraocular) pressure
(University of Pittsburgh) Piervincenzo Rizzo, PhD, professor of civil and environmental engineering at the University of Pittsburgh's Swanson School of Engineering, is leading a project that will help glaucoma patients monitor their intraocular pressure (IOP) at home, giving them and their doctors a clearer picture of eye health. The project recently received $1,099,984 from the National Science Foundation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 22, 2020 Category: International Medicine & Public Health Source Type: news

Yousefi to develop artificial intelligence to improve glaucoma research, diagnosis
(University of Tennessee Health Science Center) Siamak Yousefi, Ph.D., an assistant professor in the Department of Ophthalmology and the Department of Genetics, Genomics, and Informatics at the University of Tennessee Health Science Center, has received two grants worth more than $600,000 combined to further develop artificial intelligence (AI) to help diagnose and monitor glaucoma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 17, 2020 Category: International Medicine & Public Health Source Type: news

Study finds novel mechanism that may confer protection against glaucoma
(Louisiana State University Health Sciences Center) A team of researchers from LSU Health New Orleans Neuroscience Center of Excellence and the University of Copenhagen provides the first evidence that patients with ocular hypertension may exhibit superior antioxidant protection that promotes resistance to the elevated intraocular pressure associated with glaucoma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 17, 2020 Category: International Medicine & Public Health Source Type: news

What Can I Do to Prevent Glaucoma?
Title: What Can I Do to Prevent Glaucoma?Category: Diseases and ConditionsCreated: 9/11/2020 12:00:00 AMLast Editorial Review: 9/11/2020 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - September 11, 2020 Category: Opthalmology Source Type: news

Glaucoma: Causes, Symptoms, Types, and Treatment
Title: Glaucoma: Causes, Symptoms, Types, and TreatmentCategory: Diseases and ConditionsCreated: 9/11/2020 12:00:00 AMLast Editorial Review: 9/11/2020 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - September 11, 2020 Category: Opthalmology Source Type: news

Novel Solutions to Maintain Glaucoma Care During COVID-19 Novel Solutions to Maintain Glaucoma Care During COVID-19
In-person visits are fraught with concern, but virtual replacements won't cut it either. Dr Shuchi Patel looks at some potential alternatives.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 31, 2020 Category: Consumer Health News Tags: Ophthalmology Viewpoint Source Type: news

The human touch: using a webcam to autonomously monitor compliance during visual field assessments - Jones PR, Demaria G, Tigchelaar I, Asfaw DS, Edgar DF, Campbell P, Callaghan T, Crabb DP.
PURPOSE: To explore the feasibility of using various easy-to-obtain biomarkers to monitor non-compliance (measurement error) during visual field assessments. Methods: Forty-two healthy adults (42 eyes) and seven glaucoma patients (14 eyes) underwent tw... (Source: SafetyLit)
Source: SafetyLit - August 31, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Upstate researcher awarded $2.7 million in grants to research eye scarring, glaucoma
One of the grants expands Dr. Audrey Bernstein ’s ongoing NIH-funded work, which is focused on developing a therapeutic target for scarring in the eye in conjunction with biotech collaborators. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - August 12, 2020 Category: Universities & Medical Training Tags: News Source Type: news

Sight Sciences Announces First Patients Enrolled in ORION: A Prospective, Multicenter Clinical Trial of the OMNI Surgical System in Pseudophakic, Mild-to-Moderate Glaucoma Patients
Trial to Provide Surgeons with Prospective, Standalone Clinical Data on Microinvasive Glaucoma Surgery MENLO PARK, Calif., Aug. 10, 2020 -- (Healthcare Sales & Marketing Network) -- Sight Sciences, Inc., a growth-stage medical device company transformi... Devices, Ophthalmology Sight Sciences, OMNI Surgical System, microinvasive, glaucoma surgery, glaucoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 10, 2020 Category: Pharmaceuticals Source Type: news

Researchers discover stem cells in optic nerve that preserve vision
(University of Maryland School of Medicine) Researchers at the University of Maryland School of Medicine (UMSOM) have for the first time identified stem cells in the region of the optic nerve, which transmits signals from the eye to the brain. The finding, published this week in the journal Proceedings of the National Academy of Sciences (PNAS), presents a new theory on why the most common form of glaucoma may develop and provides potential to treat a leading cause of blindness. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 30, 2020 Category: International Medicine & Public Health Source Type: news

Want to Protect Your Eyes as You Age? Stay Away From Carbs
MONDAY, July 27, 2020 -- Glaucoma strikes many people as they age, but what if a simple dietary change could lower your risk? New research suggests it can: Scientists found a low-carbohydrate diet might protect you against the vision-robbing... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 27, 2020 Category: General Medicine Source Type: news

Glaucoma Checkups Fall by the Wayside During Pandemic
MONDAY, July 27, 2020 -- In yet another sign that the coronavirus pandemic has pushed critical medical care aside, a new survey finds many glaucoma patients have missed appointments for monitoring their eye disease. More than half (53%) of 1,051... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 27, 2020 Category: General Medicine Source Type: news

Glaucoma Checkups Fall by the Wayside During Pandemic
Title: Glaucoma Checkups Fall by the Wayside During PandemicCategory: Health NewsCreated: 7/27/2020 12:00:00 AMLast Editorial Review: 7/27/2020 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - July 27, 2020 Category: Opthalmology Source Type: news

Low-Carb Diet Does Not Up Risk for Primary Open-Angle Glaucoma
FRIDAY, July 24, 2020 -- Low-carbohydrate diets are not associated with the risk for primary open-angle glaucoma (POAG), according to a study recently published in Eye. Akiko Hanyuda, M.D., M.P.H., from the Harvard T.H. Chan School of Public Health... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 24, 2020 Category: Pharmaceuticals Source Type: news

Glaucoma Patients Worry About Managing Disease During Pandemic
WEDNESDAY, July 22, 2020 -- Glaucoma patients are concerned about managing their condition during the COVID-19 lockdowns, according to the results of a survey released by the Glaucoma Research Foundation (GRF). With support from Aerie... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 22, 2020 Category: Pharmaceuticals Source Type: news

Study points to potential new approach to treating glaucoma and Alzheimer's disease
(Vanderbilt University Medical Center) Researchers at Vanderbilt University Medical Center (VUMC) have shown for the first time that when one optic nerve in the eye is damaged, as in glaucoma, the opposite optic nerve comes to the rescue by sharing its metabolic energy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 21, 2020 Category: International Medicine & Public Health Source Type: news

Check Early and Often for Glaucoma
Title: Check Early and Often for GlaucomaCategory: Health NewsCreated: 7/17/2020 12:00:00 AMLast Editorial Review: 7/20/2020 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - July 20, 2020 Category: Opthalmology Source Type: news

Check Early and Often for Glaucoma
FRIDAY, July 17, 2020 -- Regular eye checks are crucial for people with early-stage glaucoma, a new study shows. Glaucoma is a condition in which the optic nerve that connects the eye to the brain becomes damaged. It develops slowly and affects... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 17, 2020 Category: General Medicine Source Type: news

Suicide screening in Sturge-Weber syndrome: an important issue in need of further study - Sebold AJ, Ahmed AS, Ryan TC, Cohen BA, Jampel HD, Suskauer SJ, Zabel TA, Comi AM, Rybczynski S.
BACKGROUND: Sturge-Weber syndrome is a neurocutaneous disorder associated with epilepsy, glaucoma, cognitive impairments, and a port-wine birthmark. Although individuals with Sturge-Weber syndrome are vulnerable to known risk factors for suicide, including... (Source: SafetyLit)
Source: SafetyLit - July 17, 2020 Category: International Medicine & Public Health Tags: Commentary Source Type: news

Glaucoma study findings emphasise need for regular eye checks
(University of Bradford) People with early-stage glaucoma see the contrast of visible objects in a very similar way to people without the condition, a new study has shown. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 17, 2020 Category: International Medicine & Public Health Source Type: news

Dissolving eye implant the size of a grain of sand could help save the sight of glaucoma patients 
An eye implant measuring just 0.2mm by 1mm could revolutionise the treatment of glaucoma, a condition that affects 500,000 Britons and is a leading cause of blindness. (Source: the Mail online | Health)
Source: the Mail online | Health - July 13, 2020 Category: Consumer Health News Source Type: news

Technology Bridges the Gap to Better Sight
More than 6 million Americans have vision problems that cannot be corrected by glasses or contact lenses. Companies like IrisVision are creating headsets to help them see better. (Source: NYT Health)
Source: NYT Health - July 7, 2020 Category: Consumer Health News Authors: Janet Morrissey Tags: Eyes and Eyesight Disabilities Headphones and Headsets Blindness Glaucoma Macular Degeneration Virtual Reality (Computers) IrisVision Global Inc AI July August 2020 Source Type: news

Why The Uncomfortable Test? Dr. Mallika Marshall Answers Your Coronavirus Questions
BOSTON (CBS) — Dr. Mallika Marshall is answering your coronavirus-related medical questions. If you have a question for Dr. Mallika, email her or message her on Facebook or Twitter. Dr. Mallika is offering her best advice, but as always consult your personal doctor before making any decisions about your personal health. When it comes to coronavirus testing, they always show that long swab that seems to be pushed into the brain and appears very uncomfortable. Why is this the standard method? – Harold It’s called a nasopharyngeal swab and it doesn’t go into the brain but ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 1, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Covid-19 Boston, MA Health Healthcare Status Healthwatch Syndicated Local Coronavirus Dr. Mallika Marshall Source Type: news

Exercise can slow or prevent vision loss, study finds
(University of Virginia Health System) Exercise can slow or prevent the development of macular degeneration and may benefit other common causes of vision loss, such as glaucoma and diabetic retinopathy, new research suggests. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 1, 2020 Category: International Medicine & Public Health Source Type: news

Bimatoprost Implant a Promising Weapon in Fight Against Glaucoma Bimatoprost Implant a Promising Weapon in Fight Against Glaucoma
Dr Shuchi Patel says the important question behind the recently approved intracameral biodegradable sustained-release implant isn't whether it works (it does) but rather for how long.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 26, 2020 Category: Consumer Health News Tags: Ophthalmology Viewpoint Source Type: news

Study sheds light on why retinal ganglion cells are vulnerable to glaucoma
(AlphaMed Press) Millions of sufferers of glaucoma might someday benefit from a study released in STEM CELLS in which a " disease in a dish " stem cell model was used to examine the mechanism in glaucoma that causes retinal ganglion cells (RGCs) to degenerate, resulting in loss of vision. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 18, 2020 Category: International Medicine & Public Health Source Type: news

Researchers model human stem cells to identify degeneration in glaucoma
(Indiana University School of Medicine) More than 3 million Americans have glaucoma, a serious eye condition causing vision loss. Using human stem cell models, researchers at Indiana University School of Medicine found they could analyze deficits within cells damaged by glaucoma, with the potential to use this information to develop new strategies to slow the disease process. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 11, 2020 Category: International Medicine & Public Health Source Type: news

Glaucoma Overview
Glaucoma (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 25, 2020 Category: General Medicine Source Type: news

Tissue level implants in healthy versus medically compromised patients. A cohort comparative study.
CONCLUSIONS:In terms of Success, Failure and Survival rates, tissue level implants placed in Healthy and in Medically compromised individuals showed no short-term (1 year) differences. (Source: Dental Technology Blog)
Source: Dental Technology Blog - May 20, 2020 Category: Dentistry Source Type: news

Characterizing the impact of fear of falling on activity and falls in older adults with glaucoma - E JY, Mihailovic A, Kuo PL, West SK, Friedman DS, Gitlin LN, Li T, Schrack JA, Ramulu PY.
OBJECTIVE: Fear of falling (FoF) may alter mobility in older adults, especially among those with visual impairment. Using a longitudinal prospective cohort of older glaucoma patients, we investigated whether and how FoF is associated with future falls and ... (Source: SafetyLit)
Source: SafetyLit - May 18, 2020 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Sight Sciences Introduces the Next-Generation OMNI(R) Surgical System for Microinvasive Glaucoma Surgery
Enhanced Design Offers Improved Ergonomics and Procedural Efficiency for the Only Device that Targets the Three Points of Resistance in the Conventional Outflow Pathway MENLO PARK, Calif., May 7, 2020 -- (Healthcare Sales & Marketing Network) -- Sight ... Devices, Ophthalmology, Product Launch Sight Sciences, OMNI Surgical System, microinvasive, glaucoma surgery, glaucoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 7, 2020 Category: Pharmaceuticals Source Type: news

Is Kahook Dual Blade Goniotomy a Better Option for Glaucoma? Is Kahook Dual Blade Goniotomy a Better Option for Glaucoma?
Dr Shuchi Patel on how this novel single-use ophthalmic device stacks up against conventional goniotomy and trabectome.Medscape Ophthalmology (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - May 5, 2020 Category: Opthalmology Tags: Ophthalmology Viewpoint Source Type: news

AI-supported test for very early signs of glaucoma progression
(University College London) A new test can detect glaucoma progression 18 months earlier than the current gold standard method, according to results from a UCL-sponsored clinical trial. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 3, 2020 Category: International Medicine & Public Health Source Type: news

First truly biocompatible MIGS implant from iSTAR Medical shows consistently outstanding efficacy in patients with glaucoma
Two-year final results from STAR-I trial and initial data from STAR-II European trial tout MINIject™ as a highly promising treatment WAVRE, Belgium, April 29, 2020 -- (Healthcare Sales & Marketing Network) -- iSTAR Medical SA, a clinical-stage medical ... Devices, Ophthalmology iSTAR Medical, micro-invasive glaucoma surgery, MINIject , glaucoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 29, 2020 Category: Pharmaceuticals Source Type: news

Study shows glaucoma could be successfully treated with gene therapy
A new study led by the University of Bristol has shown a common eye condition, glaucoma, could be successfully treated with a single injection using gene therapy, which would improve treatment options, effectiveness and quality of life for many patients. (Source: University of Bristol news)
Source: University of Bristol news - April 21, 2020 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Translational Health Sciences, Institutes, Institutes, Elizabeth Blackwell; Press Release Source Type: news

I am an eye surgeon but could soon be your doctor in the ICU. I'm terrified
I am fearful for the future, uncertain for how my skills will hold up when put to testCoronavirus – latest updatesSee all our coronavirus coverageI am an ophthalmologist. I am the doctor you see for your cataract surgery, the doctor your grandmother sees to have her age-related macular degeneration checked, the one who prescribed the bedtime drops to slow down your grandfather ’s glaucoma. In the next few weeks I will be the doctor your father sees for his stroke, the doctor who treats your grandmother’s heart failure, the doctor you see in A&E to treat your asthma. Potentially the doctor you meet in ...
Source: Guardian Unlimited Science - April 20, 2020 Category: Science Authors: Selina Khan Tags: Coronavirus outbreak Doctors Society Health Society Professionals Infectious diseases Science NHS Work & careers Guardian Careers Source Type: news

Eye Diseases: Resources on Conditions and Treatments
The AARP Eye Center provides vital information from top experts on eye health, including the latest on cataracts, macular degeneration, glaucoma and more. (Source: AARP.org News)
Source: AARP.org News - April 17, 2020 Category: American Health Source Type: news

Quasi-Lymphatic System in the Rodent Eye Clears Waste
Two rodent models of glaucoma have defects in the waste drainage system. (Source: The Scientist)
Source: The Scientist - April 16, 2020 Category: Science Tags: News & Opinion Source Type: news

Evaluation of fear of falling in patients with primary open-angle glaucoma and the importance of inferior visual field damage - Yuki K, Asaoka R, Ono T, Awano-Tanabe S, Murata H, Tsubota K.
This study included 273 patients (160 men and 113 women, ave... (Source: SafetyLit)
Source: SafetyLit - April 5, 2020 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Study of rare genetic disorder that effects the eyes
(Shinshu University) Small gauge vitrectomy for vitreous amyloidosis and subsequent management of secondary glaucoma in patients with hereditary transthyretin amyloidosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 3, 2020 Category: International Medicine & Public Health Source Type: news

Is Second Sight Closing up Shop?
Second Sight Medical Products is the latest medtech company to face tough losses as a result of the financial impact of the novel coronavirus (SARS-CoV-2). The Sylmar, CA-based company is laying off 84 of its 108 employees and said it intends to wind-down operations. The firm develops implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals. FDA greenlit the Argus II retinal prosthesis system in 2013. Plans now call for the Second Sight to retain an adviser experienced in winding down operations to guide the board on the next steps. Any wind down activity, if impl...
Source: MDDI - March 31, 2020 Category: Medical Devices Authors: Omar Ford Tags: Implants Business Source Type: news

Gait and balance as predictors and/or mediators of falls in glaucoma - Mihailovic A, De Luna RM, West SK, Friedman DS, Gitlin LN, Ramulu PY.
PURPOSE: To investigate the association between balance and gait measures with fall rates in glaucoma patients. METHODS: Balance and gait were measured for 239 participants with glaucoma or suspected glaucoma. Daily falls were evaluated over 24 mon... (Source: SafetyLit)
Source: SafetyLit - March 25, 2020 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Management of Glaucoma Progressing at Low Normal IOP Management of Glaucoma Progressing at Low Normal IOP
Progressive glaucoma despite low or normal IOP levels can be challenging to manage. What are the best ways to approach this condition?Current Opinion in Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 25, 2020 Category: Consumer Health News Tags: Ophthalmology Journal Article Source Type: news

Virtual Reality Can Help Assess Glaucoma-Related Visual Disability
TUESDAY, March 24, 2020 -- Vision-related disability is associated with lighting condition and task in patients with glaucoma, according to a study published online March 19 in JAMA Ophthalmology. Alexander K.N. Lam, Ph.D., from The Chinese... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 24, 2020 Category: Pharmaceuticals Source Type: news

Glaucoma after ocular chemical burns: incidence, risk factors, and outcome - Choi SH, Kim MK, Oh JY.
Effects of chemical injuries on the cornea and limbus have been widely studied; however, little is known about glaucoma after ocular chemical injuries. We herein investigated the incidence, risk factors, and outcome of glaucoma in patients with ocular chem... (Source: SafetyLit)
Source: SafetyLit - March 20, 2020 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Head Mounted Displays Could Help People Overcome Glaucoma Challenges
A recent study from the Crabb Lab, at City, University of London shows how commercially available head-mounted displays (HMD) can be used to simulate the day-to-day challenges faced by people with glaucoma. Twenty-two volunteers who did not have glaucoma took part in the study and wore an HMD while performing various tasks in either virtual or augmented reality. The study is published in the online journal, npj Digital Medicine. In the virtual reality task, participants were placed in a simulation of a typical, 'cluttered' house. Moving their eyes and head allowed them to look around it in order to find a mobile phone hidd...
Source: MDDI - March 17, 2020 Category: Medical Devices Authors: MDDI Staff Tags: Digital Health R & Source Type: news

Nigeria: Over 1 Million Blind Adults Live in Nigeria - Nzelu
[Vanguard] As the World marks this year's World Glaucoma Week, a medical expert, Dr Abia Nzelu has said that despite the fact that vision is the most valuable of all human senses, every five seconds one person in the world goes blind even as she said that over 1 million blind adults live in Nigeria. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 10, 2020 Category: African Health Source Type: news

Modern virtual and augmented reality device can help simulate sight loss
(City University London) Published today, during World Glaucoma Week 2020, a new study demonstrates how commercially available head mounted displays (HMD) can be used to simulate the day-to-day challenges faced by people with sight loss from glaucoma. The study, from the Crabb Lab, at City, University of London, suggests potential applications of the technology could include helping policymakers better assess the impact of visual impairment on patients, and helping architects to design more accessible buildings. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 10, 2020 Category: Biology Source Type: news

FDA OKs First Biodegradable Implant to Lower IOP FDA OKs First Biodegradable Implant to Lower IOP
Bimatoprost implant (Durysta) delivers 10 µ g of the prostaglandin analog and is an alternative to daily topical eye drops in patients with open-angle glaucoma or ocular hypertension.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 6, 2020 Category: Drugs & Pharmacology Tags: Ophthalmology News Alert Source Type: news

FDA Approves Durysta (bimatoprost implant) to Lower Intraocular Pressure In Open-Angle Glaucoma or Ocular Hypertension Patients
DUBLIN, March 5, 2020 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company with more than 70 years of heritage in eye care, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 5, 2020 Category: Drugs & Pharmacology Source Type: news